Chronic Lymphocytic Lymphoma drug trial of Zydelig combined with Rituxan and Treanda unblinded early due to success.

“Sing praises for another medical breakthrough of research by a publicly traded American company. Gilead is in Foster City, California. Many of us have been with loved ones as they died with a leukemia and it brings tears for years. Yes, it still does, as I write this. “Bill Chesnut, MD

Chronic Lymphocytic Lymphoma drug trial of Zydelig combined with Rituxan and Treanda unblinded early due to success.

Reuters (11/17, Berkrot) reports that a Phase III clinical trial of Gilead Sciences’ chronic lymphocytic leukemia (CLL) treatment was unblinded after independent observers concluded the drug was significantly effective at slowing the progression of the disease. The study tested Gilead’s Zydelig (idelalisib) in combination with Rituxan (rituximab) and Treanda (bendamustine), compared to Rituxan and Treanda alone.

 

AMA News, November, 2015.